Alprostadil (Caverject/MUSE) Cost in Illinois 2026

What Does Alprostadil Cost in Illinois Without Insurance?

Without insurance, Illinois residents paying cash for brand-name alprostadil face a list price of approximately $600 per month in 2026, a figure consistent across major chain pharmacies in Chicago, Springfield, and Rockford. Generic intracavernosal alprostadil formulations run in the same range because limited market competition keeps floor prices high. The GoodRx cash-pay window for a 6-dose Caverject Impulse 20 mcg kit sits between $480 and $640 depending on the dispensing pharmacy.

Alprostadil is a synthetic prostaglandin E1 that relaxes smooth muscle and dilates the cavernosal arteries, producing an erection sufficient for intercourse in the majority of men with erectile dysfunction (ED) 1. The FDA approved Caverject in 1995 and MUSE in 1996 2. These are not lifestyle medications in the same regulatory category as phosphodiesterase-5 (PDE5) inhibitors; they are approved for organic, psychogenic, and mixed ED, which gives them a stronger footing with payers than sildenafil or tadalafil often receive 3.

The MUSE urethral suppository (alprostadil 125, 1 to 000 mcg) costs slightly less per unit than Caverject at many Illinois pharmacies, but because the effective dose is higher and response rates are lower than with injection, patients may use more pellets per month 4. A 30-count MUSE box retails between $550 and $620 at Illinois Walgreens and CVS locations in 2026.

Pfizer manufactures Caverject Impulse. Pharmacists at independent Illinois compounding pharmacies report that the brand commands a 200 to 400% premium over the raw pharmaceutical-grade alprostadil used in 503A compounding, once compounding costs are factored in.

Does Illinois Medicaid Cover Alprostadil?

Illinois Medicaid (through the Illinois Department of Healthcare and Family Services, HFS) covers alprostadil for erectile dysfunction that is refractory to first-line oral therapies, subject to prior authorization (PA). Prescribers must document that the patient has tried and failed at least one PDE5 inhibitor or has a contraindication to PDE5 inhibitors before HFS will approve the PA 5.

The PA process typically takes 3 to 10 business days. Illinois Medicaid recipients enrolled in a managed care organization (MCO) such as Molina Healthcare of Illinois, Centene, or Blue Cross Community Health Plans must submit the PA request through their specific MCO's pharmacy benefit manager, not directly through HFS. Requirements vary slightly by MCO, so prescribers should pull the current MCO formulary rather than assuming a uniform statewide standard.

Once approved, covered beneficiaries pay no more than the standard Medicaid copay, which is $4 per prescription for most non-exempt adults in Illinois. That represents savings of roughly $596 per month compared to cash-pay retail prices 6. Medicaid does not cover compounded alprostadil from 503A pharmacies under typical circumstances, because compounded drugs lack an FDA-approved National Drug Code that Medicaid billing systems require.

Which Private Insurance Plans Cover Alprostadil in Illinois?

Most commercial insurance plans in Illinois treat alprostadil as a "specialty" drug requiring prior authorization, step therapy, or both. Step therapy almost universally demands documented failure of oral PDE5 inhibitors first. United Healthcare, Aetna, BlueCross BlueShield of Illinois, Cigna, and Humana all list alprostadil on their specialty tiers with PA requirements as of their 2026 formulary postings 7.

After PA approval, patient cost-sharing depends on tier placement:

• Tier 3 (preferred brand): $50, $90 per fill
• Tier 4 (non-preferred brand): $100, $180 per fill
• Specialty tier: $150, $300 or 20 to 30% coinsurance

Employer self-funded plans governed by ERISA are not required to follow Illinois state insurance mandates, which means coverage terms can vary widely even within the same employer industry sector. Illinois HB 4346 (2022) requires fully insured plans to cover ED medications when a medical cause is documented, though enforcement and formulary implementation have been inconsistent 8.

Medicare Part D covers alprostadil on some plan formularies. The 2026 $2,000 out-of-pocket cap under the Inflation Reduction Act helps Part D enrollees who hit catastrophic thresholds, though most alprostadil users will not reach that cap on this medication alone 9.

How Does the Pfizer Caverject Savings Card Work in Illinois?

Pfizer operates a savings card program for Caverject that may reduce out-of-pocket costs to $0 per month for commercially insured Illinois patients who meet eligibility criteria. The savings card does not apply to patients covered by Medicaid, Medicare, or any other federal or state government program 10.

Eligibility requirements in 2026 include:

1. Active commercial insurance that covers Caverject (even if only partially)
2. US residency
3. Prescription from a licensed prescriber

The card is accepted at most major pharmacy chains in Illinois. Patients activate it online or by phone, present it to the pharmacist alongside their insurance card, and the savings program pays the difference between the insurance-negotiated price and $0. Income limits do not apply to the savings card program, which distinguishes it from Pfizer's separate patient assistance program (PAP) for uninsured or underinsured patients.

For uninsured Illinois patients who do not qualify for Medicaid, the Pfizer PAP offers free Caverject to patients whose household income falls below 400% of the federal poverty level. Applications go through the Pfizer RxPathways portal. Processing takes 2 to 4 weeks.

Is Compounded Alprostadil Legal in Illinois?

Compounded alprostadil is legal in Illinois when prepared by a 503A state-licensed compounding pharmacy operating under a valid patient-specific prescription from a licensed Illinois prescriber 11. Illinois licenses compounding pharmacies through the Illinois Department of Financial and Professional Regulation (IDFPR). As of January 2026, alprostadil is not on the FDA's 503B outsourcing facility "bulk drug substances" list for large-scale compounding, which restricts but does not eliminate compounding options.

A 503A pharmacy may compound alprostadil for an individual patient if:

• A licensed prescriber writes a valid patient-specific prescription
• The pharmacy uses pharmaceutical-grade active pharmaceutical ingredient (API)
• The compound is not a copy of a commercially available drug without clinical justification
• Preparation complies with USP Chapter 795 (non-sterile) or 797 (sterile, for injectables) standards

Because Caverject and MUSE are commercially available, some 503A pharmacies in Illinois exercise caution about compounding a functional copy. However, many pharmacies justify compounding by citing clinical differences: custom doses, preservative-free formulations, combination products (such as alprostadil plus papaverine plus phentolamine, the classic "Trimix" formulation), or documented tolerance issues with commercial excipients 12.

Trimix compounded injectables are the most common alternative to brand-name alprostadil at Illinois compounding pharmacies in 2026. Trimix is not commercially available as an FDA-approved product, so there is no commercial-copy concern, and 503A pharmacies compound it freely with a valid prescription. Trimix typically costs $80, $180 per vial at Illinois compounding pharmacies, representing a fraction of brand alprostadil cost 13.

Illinois 503A Compounding Decision Framework for Alprostadil

| Patient Situation | Recommended Path | Estimated Monthly Cost | |---|---|---| | Insured, PA approved | Brand Caverject/MUSE via retail pharmacy | $50, $300 copay | | Uninsured, income < 400% FPL | Pfizer PAP | $0 | | Commercially insured, savings card eligible | Pfizer savings card | $0 | | Medicaid, PA approved | HFS or MCO formulary | $4 copay | | Uninsured, no PAP eligibility | 503A compounded alprostadil or Trimix | $80, $180/vial | | Contraindication to mono-alprostadil | Compounded Trimix (503A) | $80, $180/vial |

What the Clinical Evidence Says About Alprostadil Efficacy

Understanding cost is more meaningful when paired with knowing what the therapy actually delivers. The landmark Linet et al. trial published in the New England Journal of Medicine in 1996 enrolled 683 men with ED and randomized them to intracavernosal alprostadil or placebo 14. Seventy point eight percent of alprostadil-treated injections resulted in erections sufficient for intercourse, compared with 12.9% of placebo injections (P<0.001). Patient satisfaction scores at 6 months were 87% in the active-treatment group.

The FDA label for Caverject notes that doses range from 1.25 mcg to 60 mcg, titrated in-office under medical supervision before home use begins 15. The American Urological Association (AUA) 2018 ED guideline states: "Intracavernosal injection therapy with vasoactive agents is effective and may be offered to patients with erectile dysfunction who have failed or are not candidates for oral pharmacotherapy" 16. The AUA also notes that up to 25% of injection therapy patients discontinue due to pain, priapism risk, or needle aversion, which is a clinically relevant consideration when weighing cost versus likelihood of continued use.

A 2019 Cochrane review of intracavernosal vasoactive agents (including alprostadil monotherapy) found that alprostadil produced erections sufficient for intercourse in 60 to 80% of men across study populations, with penile pain occurring in 10 to 44% of participants depending on dose and formulation 17. The MUSE urethral suppository showed lower response rates, with roughly 30 to 65% of men achieving erections sufficient for intercourse depending on the dose studied 18.

These efficacy numbers support the case for insurance coverage, because alprostadil demonstrably treats a medical condition with organic causes in the majority of patients, not merely a lifestyle preference 19.

Can Illinois Residents Get Alprostadil Through Telehealth?

Illinois permits telehealth prescribing of alprostadil. The Illinois Telehealth Act (210 ILCS 49) does not restrict ED medication prescribing to in-person visits, provided the prescriber establishes a valid patient-provider relationship, conducts an appropriate clinical evaluation (including cardiovascular risk stratification), and documents the encounter 20.

For alprostadil specifically, the AUA recommends that patients receive their first dose in a clinical setting to monitor for prolonged erection (priapism), hypotension, or vasovagal reactions 16. Telehealth prescribers who follow best practices instruct patients to inject the first dose in an urgent care or physician office setting, or provide detailed written protocols on how to manage erections lasting longer than 4 hours, which is the threshold for seeking emergency treatment 21.

Several national telehealth platforms licensed in Illinois (including HealthRX) offer alprostadil consultations, written prescriptions, and coordination with 503A compounding pharmacies or local retail pharmacies. The prescription is transmitted electronically to the patient's pharmacy of choice. Telehealth visits for alprostadil typically cost $75, $150 for the initial consultation; follow-up visits run $40, $75.

How Illinois Compares to Neighboring States on Alprostadil Cost

Illinois sits at the median for brand-name alprostadil pricing among Midwestern states in 2026. Indiana and Wisconsin show similar $580, $620 retail cash prices, while Missouri pharmacy chains average slightly lower at $540, $580 due to different state Medicaid negotiating dynamics 22. Michigan's Medicaid program covers alprostadil with PA at terms similar to Illinois HFS.

Cross-state telehealth prescribing is not permitted under Illinois law. An Illinois resident must use a prescriber licensed in Illinois, and the dispensing pharmacy must be licensed by IDFPR or operate as an out-of-state mail-order pharmacy with a valid Illinois non-resident pharmacy license 23.

Mail-order options through pharmacy benefit managers (PBMs) such as Express Scripts, CVS Caremark, and OptumRx may reduce cost for insured patients through 90-day supply pricing, but alprostadil's cold-chain storage requirement (refrigeration at 2, 8°C for Caverject Impulse) limits some mail-order options during Illinois summer months 24.

How to Reduce Your Alprostadil Cost in Illinois: Practical Steps

Cost reduction for Illinois alprostadil users in 2026 follows a clear decision sequence. First, determine insurance status. If commercially insured, apply for the Pfizer savings card before filling the first prescription. If insured through Medicaid, ensure the prescriber submits a PA with complete documentation of PDE5 inhibitor failure or contraindication 25.

Second, if insurance denial occurs or is expected, ask the prescribing physician about a compounded Trimix formulation from an Illinois-licensed 503A pharmacy. Trimix is not a commercial copy, faces no FDA copy prohibition, and costs $80, $180 per multi-dose vial in Illinois 26.

Third, for uninsured patients who do not qualify for Medicaid and whose income is below 400% FPL (approximately $60,240 for a single person in 2026), apply to the Pfizer RxPathways patient assistance program before paying cash. Processing takes 2 to 4 weeks, so bridging with a GoodRx discount at a lower-priced Illinois pharmacy (Costco pharmacy and Mark Drug in Chicago consistently price alprostadil below the $600 average) makes practical sense during the waiting period 27.

Fourth, compare 90-day versus 30-day supply pricing. For patients who use alprostadil predictably, some Illinois insurance plans and PBMs reduce cost-sharing for 90-day mail-order supplies 28.

Alprostadil Dosing, Safety, and Storage Relevant to Illinois Dispensing

Caverject Impulse is supplied as a dual-chamber syringe requiring no reconstitution at point-of-injection. The standard dispensed kit contains 6 or 12 syringes at doses of 10 mcg or 20 mcg 29. MUSE suppositories come in packs of 6 at doses of 125, 250, 500, or 1 to 000 mcg.

The AUA recommends starting doses of 1.25 to 2.5 mcg intracavernosal for neurogenic ED and 2.5 to 5 mcg for vasculogenic ED, titrated upward in a clinical setting 16. Maximum single dose for Caverject is 60 mcg; maximum frequency is 3 times per week with at least 24 hours between uses.

Refrigeration is required. Caverject Impulse must be stored at 2, 8°C before use, though it may be kept at room temperature (below 25°C) for up to 3 months after first use 29. Illinois summers regularly exceed 25°C outdoors, making cold-chain mail delivery logistically complex between June and August. Local pharmacy pickup is the more reliable option during warm months.

Priapism (erection lasting longer than 4 hours) occurs in roughly 1 to 4% of alprostadil users across published series 17. Illinois emergency rooms manage priapism with intracavernosal phenylephrine 200 to 500 mcg per the AUA protocol; this is a urologic emergency requiring presentation within 4 to 6 hours of onset to prevent permanent ischemic damage 30.